DE602005021873D1 - Neues impfstoffadjuvans und dessen herstellung und verwendung - Google Patents
Neues impfstoffadjuvans und dessen herstellung und verwendungInfo
- Publication number
- DE602005021873D1 DE602005021873D1 DE602005021873T DE602005021873T DE602005021873D1 DE 602005021873 D1 DE602005021873 D1 DE 602005021873D1 DE 602005021873 T DE602005021873 T DE 602005021873T DE 602005021873 T DE602005021873 T DE 602005021873T DE 602005021873 D1 DE602005021873 D1 DE 602005021873D1
- Authority
- DE
- Germany
- Prior art keywords
- manufacture
- vaccine adjuvant
- new vaccine
- present
- skin extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Seeds, Soups, And Other Foods (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55263604P | 2004-03-12 | 2004-03-12 | |
PCT/US2005/008400 WO2005089262A2 (en) | 2004-03-12 | 2005-03-14 | Novel peanut skin extract as a vaccine adjuvant |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005021873D1 true DE602005021873D1 (de) | 2010-07-29 |
Family
ID=34994226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005021873T Active DE602005021873D1 (de) | 2004-03-12 | 2005-03-14 | Neues impfstoffadjuvans und dessen herstellung und verwendung |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1742656B1 (de) |
AT (1) | ATE471155T1 (de) |
CA (1) | CA2559272C (de) |
DE (1) | DE602005021873D1 (de) |
DK (1) | DK1742656T3 (de) |
WO (1) | WO2005089262A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879342B2 (en) * | 2004-03-12 | 2011-02-01 | Univ. Of Georgia Research Foundation, Inc. | Vaccine adjuvant and making and using the same |
CN102046197A (zh) | 2008-05-29 | 2011-05-04 | 英特威国际有限公司 | 球虫病疫苗 |
WO2010056709A2 (en) | 2008-11-13 | 2010-05-20 | Intervet International B.V. | Eimeria vaccine for turkeys |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5780325A (en) | 1980-09-05 | 1982-05-19 | Nat Res Dev | Coccidial disease vaccine |
US4458630A (en) | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
US4639372A (en) | 1984-06-29 | 1987-01-27 | Merck & Co., Inc. | Coccidiosis vaccine |
US5279960A (en) | 1984-07-05 | 1994-01-18 | Enzon Corp. | 25 KD coccidial antigen of eimeria tenella |
DE3785404T2 (de) | 1986-08-18 | 1993-07-29 | British Tech Group | Impfstoffe. |
US4808404A (en) | 1988-01-11 | 1989-02-28 | A. H. Robins Company, Inc. | Live vaccine for coccidiosis utilizing coccidial sporozoites |
ZA893740B (en) * | 1988-06-03 | 1990-02-28 | Hoffmann La Roche | Recombinant coccidiosis vaccines |
ZA894726B (en) | 1988-06-27 | 1990-03-28 | Akzo Nv | Coccidiosis vaccine |
US5068104A (en) | 1988-08-01 | 1991-11-26 | A. H. Robins Company Incorporated | Live vaccine for coccidiosis utilizing coccidial sporozoites |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
ZA902147B (en) | 1989-03-28 | 1990-12-28 | Akzo Nv | Coccidiosis vaccine |
ATE94208T1 (de) | 1989-06-21 | 1993-09-15 | Akzo Nv | Eimeria tenella-vakzin. |
JPH07500483A (ja) | 1991-03-14 | 1995-01-19 | ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド | 組換え体抗コクシジアワクチン |
ZA924203B (en) | 1991-06-18 | 1993-03-31 | Akzo Nv | Coccidiosis poultry vaccine |
DE69230037T2 (de) | 1991-07-12 | 2000-01-05 | Pfizer | Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien |
ATE232903T1 (de) | 1993-11-12 | 2003-03-15 | Akzo Nobel Nv | Impfstoff gegen geflügelkokzidose |
NZ272945A (en) | 1994-09-16 | 1997-12-19 | Akzo Nobel Nv | Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use |
US5554645A (en) | 1994-10-03 | 1996-09-10 | Mars, Incorporated | Antineoplastic cocoa extracts and methods for making and using the same |
US6777005B1 (en) | 1994-10-03 | 2004-08-17 | Mars, Incorporated | Foods containing a cocoa polyphenol additive |
US5566064A (en) | 1995-05-26 | 1996-10-15 | Apple Computer, Inc. | High efficiency supply for electroluminescent panels |
US5976580A (en) * | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
US6297273B1 (en) | 1996-04-02 | 2001-10-02 | Mars, Inc. | Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
US6696485B1 (en) | 1996-04-02 | 2004-02-24 | Mars, Incorporated | Procyanidin and cyclo-oxygenase modulator compositions |
US6469053B1 (en) | 1996-04-02 | 2002-10-22 | Mars Incorporated | Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
US6207842B1 (en) | 1997-10-09 | 2001-03-27 | Mars Incorporated | Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6805883B2 (en) | 1998-03-12 | 2004-10-19 | Mars, Incorporated | Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide |
US6156912A (en) | 1999-04-09 | 2000-12-05 | Mars, Incorporated | 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation |
US7015338B1 (en) | 1999-04-15 | 2006-03-21 | Mars Incorporated | Synthetic methods for preparing procyanidin oligomers |
US6476241B1 (en) | 2000-09-05 | 2002-11-05 | Mars Incorporated | Synthesis of 4α-arylepicatechins |
JP2006510671A (ja) | 2002-12-09 | 2006-03-30 | ユニヴァーシティー オヴ ジョージア リサーチ ファンデーション インク | コクシジウム症ワクチン及びその製造並びに使用方法 |
-
2005
- 2005-03-14 DE DE602005021873T patent/DE602005021873D1/de active Active
- 2005-03-14 AT AT05733210T patent/ATE471155T1/de not_active IP Right Cessation
- 2005-03-14 EP EP05733210A patent/EP1742656B1/de active Active
- 2005-03-14 WO PCT/US2005/008400 patent/WO2005089262A2/en active Application Filing
- 2005-03-14 CA CA2559272A patent/CA2559272C/en active Active
- 2005-03-14 DK DK05733210.8T patent/DK1742656T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1742656B1 (de) | 2010-06-16 |
ATE471155T1 (de) | 2010-07-15 |
WO2005089262A3 (en) | 2006-10-12 |
EP1742656A4 (de) | 2007-11-14 |
DK1742656T3 (da) | 2010-07-19 |
CA2559272C (en) | 2015-12-01 |
EP1742656A2 (de) | 2007-01-17 |
CA2559272A1 (en) | 2005-09-29 |
WO2005089262A2 (en) | 2005-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
PH12014501836A1 (en) | Novel adjuvant compositions | |
IN2014DN08830A (de) | ||
UA99659C2 (uk) | Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування | |
WO2005087238A3 (en) | Method for stimulating the immune, inflammatory or neuroprotective response | |
WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
CA2763359C (en) | New human rotavirus strains and vaccines | |
GB2386072A (en) | Novel vaccine | |
CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
EP1471936A4 (de) | Hiv-vakzine und anwendungsverfahren | |
DE60336588D1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
MX344544B (es) | Vacuna para paludismo en etapa sanguinea. | |
DE602005021873D1 (de) | Neues impfstoffadjuvans und dessen herstellung und verwendung | |
NO20045587L (no) | Liposom vaksineformulering for finne-fisk | |
WO2007028985A3 (en) | Adjuvanted vaccine | |
WO2007014179A3 (en) | Method for controlling immunodominance | |
BR112012033751A2 (pt) | composição de vacina, célula, adjuvante, método de vacinar um paciente contra e. canis e processos para produzir a composição de vacina e o antígeno de e. canis | |
UA104138C2 (en) | Novel adjuvant compositions | |
TN2010000338A1 (en) | Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant | |
WO2008100142A3 (en) | Vaccine formulation |